Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Alexopoulos

Showing results (1-10 of 387) with videos related to

Pageof 39
Sort By:
International Journal of Cardiology|February 8, 2011
Acute myocardial infarction late following stent implantation: Incidence, mechanisms and clinical presentationDimitrios Alexopoulos
Evidence-Based Medicine|June 18, 2015
Long-term ticagrelor therapy in patients with prior myocardial infarction significantly reduces ischaemic events, albeit with increased bleedingDimitrios Alexopoulos
American Heart Journal|May 22, 2012
Regarding the "Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study"Dimitrios Alexopoulos
International Journal of Cardiology|May 6, 2022
In the search of the 'sweet spot' for aspirin discontinuation time in AF patients post PCIDimitrios Alexopoulos
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|November 12, 2020
Ticagrelor and omeprazole: A desirable combination in post MI patients?Dimitrios Alexopoulos
Platelets|July 27, 2011
Prasugrel resistance: fact or fictionDimitrios Alexopoulos
Cardiology|January 25, 2014
p2y12 receptor inhibitors in acute coronary syndromes: from the research laboratory to the clinic and vice versaDimitrios Alexopoulos
Expert Review of Hematology|September 21, 2012
Prediction of clopidogrel efficacy and safety: phenotyping and/or genotyping?Dimitrios Alexopoulos
International Journal of Cardiology|October 16, 2012
Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: facing a crossroad?Dimitrios Alexopoulos
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 7, 2012
Mortality and cardiovascular and bleeding outcomes in patients with CKD receiving antiplatelet therapyDimitrios Alexopoulos
Pageof 39

Showing results (1-10 of 387) with videos related to

Sort By:
Pageof 39
International Journal of Cardiology|February 8, 2011
Acute myocardial infarction late following stent implantation: Incidence, mechanisms and clinical presentationDimitrios Alexopoulos
Evidence-Based Medicine|June 18, 2015
Long-term ticagrelor therapy in patients with prior myocardial infarction significantly reduces ischaemic events, albeit with increased bleedingDimitrios Alexopoulos
American Heart Journal|May 22, 2012
Regarding the "Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: Results of the Effect of Platelet Inhibition According to Clopidogrel Dose in Patients with Chronic Kidney Disease (PIANO-2 CKD) randomized study"Dimitrios Alexopoulos
International Journal of Cardiology|May 6, 2022
In the search of the 'sweet spot' for aspirin discontinuation time in AF patients post PCIDimitrios Alexopoulos
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|November 12, 2020
Ticagrelor and omeprazole: A desirable combination in post MI patients?Dimitrios Alexopoulos
Platelets|July 27, 2011
Prasugrel resistance: fact or fictionDimitrios Alexopoulos
Cardiology|January 25, 2014
p2y12 receptor inhibitors in acute coronary syndromes: from the research laboratory to the clinic and vice versaDimitrios Alexopoulos
Expert Review of Hematology|September 21, 2012
Prediction of clopidogrel efficacy and safety: phenotyping and/or genotyping?Dimitrios Alexopoulos
International Journal of Cardiology|October 16, 2012
Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: facing a crossroad?Dimitrios Alexopoulos
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 7, 2012
Mortality and cardiovascular and bleeding outcomes in patients with CKD receiving antiplatelet therapyDimitrios Alexopoulos
Pageof 39